Hubungan Komorbid Hipertensi dengan Kematian pada Kasus Konfirmasi COVID-19 di DKI Jakarta, Maret-Agustus 2020

Wulandari, Endang Widuri; Ronoatmodjo, Sudarto; Salama, Ngabila

doi:10.33221/jikm.v10i04.1026

Cited by 5 publications

(6 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Hipertensi dapat menyebabkan terjadinya penyakit gagal ginjal kronis yang dapat memperparah gejala COVID-19, sehingga pasien dengan COVID-19 yang usia lanjut lebih berisiko, bahkan dapat meningkatkan risiko kematian. 18 Namun, hasil penelitian menunjukkan hal sebaliknya, banyaknya kejadian hipertensi dalam kehamilan dengan Seharusnya, kelompok usia yang lebih muda mendapatkan informasi lebih banyak mengenai gejala hipertensi dalam kehamilan dan COVID-19 sehingga dapat mencegah sebelum terjadinya hipertensi dalam kehamilan dengan COVID-19. 19 Berdasarkan penelitian ini, tidak hanya kelompok usia 20-35 saja yang perlu diperhatikan, tetapi usia berisiko juga perlu diperhatikan karena ibu pada usia <20 tahun alat reproduksinya belum matang, ukuran uterus wanita belum normal untuk hamil, selain itu emosi ibu cenderung labil, dan mental belum matang sehingga memerlukan perhatian lebih untuk memenuhi keperluan zat gizi selama kehamilan yang kurang.…”

Section: Pendahuluanunclassified

Gambaran Kejadian Ibu Hipertensi Dalam Kehamilan Dengan Covid-19 Di Rsud Ulin Banjarmasin Periode Mei 2020-Juni 2021

Arumningtyas

Armanza

Wasilah³

et al. 2023

View full text Add to dashboard Cite

Hypertension in pregnancy is one of the most common causes of maternal death in Indonesia as well as in other developed countries such as the United States. The cause of preeclampsia is currently uncertain, but there are several risk factors that can increase the occurrence of preeclampsia. Coronavirus disease 19 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2). Pregnant women and hypertension are factors that can increase the risk of COVID-19. If not treated properly, hypertension in pregnancy can cause maternal and fetal morbidity and mortality. The purpose of this study was to describe the incidence of maternal hypertension in pregnancy with COVID-19 based on age, parity, gravida, history of preeclampsia, and education at Ulin Hospital Banjarmasin for the period May 2020-June 2021. This research method was descriptive with data collection through medical records. patient. The sampling technique used is total sampling. The subjects of this study amounted to 88 patients. This study shows preeclampsia is the type of hypertension in pregnancy with COVID-19 being the most common, which was 57 patients (64.7%). Most of the patients were in the age range of 20-35 years, as many as 52 patients (59.3%). Based on parity, most of the cases occurred in mothers with multilipara as many as 39 patients (44.3 %). Gravida was found mostly in mothers with multigravida as many as 63 patients (71.6%). Based on a history of preeclampsia, patients who did not have a history of preeclampsia were found to be more than patients who had a history of preeclampsia, namely as many as 52 patients (59.1%) and the majority of patients' education at the high school level, which was 29 patients (32.9%).

show abstract

Section: Pendahuluanunclassified

Gambaran Kejadian Ibu Hipertensi Dalam Kehamilan Dengan Covid-19 Di Rsud Ulin Banjarmasin Periode Mei 2020-Juni 2021

Arumningtyas

Armanza

Wasilah³

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Penelitian ini menunjukkan hasil yang sama dengan penelitian lain yang menunjukkan bahwa pasien dengan komorbid hipertensi dapat menyebabkan kematian akibat COVID-19 dibandingkan dengan penyakit penyerta lainnya dan pasien tanpa penyakit penyerta. 7,14 Titik awal infeksi SARS-CoV-2 adalah reseptor inang, yaitu ACE-2 adalah protein multifungsi. 7 Lonjakan SARS-CoV-2 berikatan dengan reseptor ACE-2, yang memfasilitasi masuknya virus ke dalam sel epitel alveolar paru-paru dan reproduksi.…”

Section: Hasil Penelitian Dan Pembahasanunclassified

“…15 Komorbid hipertensi akan memperparah infeksi dengan peningkatan jumlah reseptor ACE-2 yang menyebabkan virus lebih mudah menyebar dalam tubuh dan dapat memperparah bahkan menyebabkan kematian. 14 Pada penelitian ini kelompok komorbid hipertensi merupakan penyakit tunggal tidak disertai penyakit lain. Hal ini karena pada penelitian lain menyatakan bahwa komorbid selain hipertensi yaitu di antara banyak faktor penyerta, diabetes melitus merupakan faktor komorbiditas yang meningkatkan keparahan dan risiko kematian pada pasien COVID-19.…”

Section: Hasil Penelitian Dan Pembahasanunclassified

Hipertensi sebagai Komorbid Tunggal Merupakan Faktor Risiko Kematian COVID-19: Case-Control Study

Salha¹,

Suherlan²,

Muflihah³

2023

BCSMS

View full text Add to dashboard Cite

Abstract. The mortality of Coronavirus Disease 2019 (COVID-19) is associated with elderly age, gender, and comorbid hypertension. Studies examining the relationship between comorbid hypertension and COVID-19 mortality by controlling for age and gender is limited. This study aimed to analyze hypertension as a risk factor for the mortality of COVID-19 by controlling age and gender. This case-control study medical records. The subjects were confirmed COVID-19 patients who were hospitalized at dr. Slamet Garut period December 2020 – December 2021. The case group was COVID-19 patients who died following hospitalisation. The control group was survived COVID-19 patients who were individually matched with the case group in the age and sex. Comorbid hypertension is hypertension was defined as alone without other comorbidities. A total of 322 subjects consisting of 161 patients in the case group and 161 patients in the control group. In the case group, 151 patients (93.8%) were elderly people, 83 patients (51.5%) were female, and 87 patients (54%) had comorbid hypertension. Comorbid hypertension was present in 87 people (54.0%) of the case group dan 24 people (14.9%) of the control. Hypertension has a significant relationship with the mortality of COVID-19 (p=0.000) with OR 6.711. This study concludes that COVID-19 patients with hypertension as a single comorbid have a 6 times higher risk of death than patients in the same age and sex. Abstrak. Kematian Coronavirus Disease 2019 (COVID-19) berhubungan dengan usia lansia, jenis kelamin, dan komorbid hipertensi. Penelitian yang mengkaji hubungan hipertensi dengan kematian COVID-19 dengan mengendalikan faktor usia dan jenis kelamin masih jarang. Penelitian ini bertujuan menganalisis faktor resiko hipertensi pada kematian COVID-19 dengan mengendalikan usia dan jenis kelamin. Penelitian case control ini menggunakan rekam medis. Subjek penelitian adalah pasien terkonfirmasi COVID-19 yang dirawat inap di RSUD dr. Slamet Garut periode Desember 2020 – Desember 2021. Kelompok case adalah pasien COVID-19 yang meninggal. Kelompok control adalah pasien COVID-19 tidak meninggal yang sesuai usia dan jenis kelamin pada setiap subjek (individual matched) kelompok case. Komorbid hipertensi didefinisikan penyakit hipertensi saja tanpa disertai komorbid lain. Subjek penelitian berjumlah 322 orang yang terdiri dari 161 kelompok case dan 161 kelompok control. Pasien COVID-19 meninggal berusia lansia sebanyak 151 orang (93.8%), perempuan 83 orang (51.5%) dan memiliki komorbid hipertensi 87 orang (54%). Komorbid hipertensi pada kelompok case sebanyak 87 orang (54.0%), sedangkan kelompok control 24 orang (14.9%). Hipertensi memiliki hubungan dengan kematian COVID-19 secara signifikan (p=0.000) dengan OR 6.711. Kesimpulan penelitian ini pasien COVID-19 adalah komorbid tunggal hipertensi memiliki resiko 6 kali lebih tinggi untuk meninggal dibandingkan pasien lain pada usia dan jenis kelamin sama.

show abstract

“…This can lel ad to Acul tel Rel spiratory Distrel ss Syndromel (ARDS) with a risk of del ath. In patiel nts with comorbid hypel rtel nsion, thel rel can bel immul nel disordel rs that caul sel cytokinel storms, lel ading to complications of mul lti-organ failul rel lel ading to del ath (2).…”

Section: Introductionmentioning

confidence: 99%

The Impact of Hypertension Severity on Mortality Rate in Covid-19: A Literature Review

Mutia Mutiara,

Kemala Dewi,

Zaky Romadhon

2023

IJRP

View full text Add to dashboard Cite

Background: On January 30, 2020, the 2019 coronavirus epidemic (2019-nCoV) was assessed as potentially harmful to humans by the World Health Organization (WHO). On the same date, the WHO also stated that 7,818 cases had been reported and 170 deaths had been recorded. On March 11, 2020, WHO published that the coronavirus disease outbreak was categorized as a pandemic. (WHO, 2021) The Indonesian state recorded that the first Indonesian citizen who was declared infected with COVID-19 came from Depok City on March 2, 2020 COVID-19 patients with comorbid or comorbid diseases have a higher mortality rate compared to patients without congenital diseases. One of the most common comorbidities found in COVID-19 patients is hypertension. The prevalence of COVID-19 patients with hypertension reached 56.6%.

show abstract

Hubungan Komorbid Hipertensi dengan Kematian pada Kasus Konfirmasi COVID-19 di DKI Jakarta, Maret-Agustus 2020

Cited by 5 publications

References 20 publications

Gambaran Kejadian Ibu Hipertensi Dalam Kehamilan Dengan Covid-19 Di Rsud Ulin Banjarmasin Periode Mei 2020-Juni 2021

Gambaran Kejadian Ibu Hipertensi Dalam Kehamilan Dengan Covid-19 Di Rsud Ulin Banjarmasin Periode Mei 2020-Juni 2021

Hipertensi sebagai Komorbid Tunggal Merupakan Faktor Risiko Kematian COVID-19: Case-Control Study

The Impact of Hypertension Severity on Mortality Rate in Covid-19: A Literature Review

Contact Info

Product

Resources

About